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I N T R O D U C T I O N
The transient receptor potential vanilloid 1 (TRPV1) is 
a nonselective cation channel of the transient receptor 
potential superfamily predominantly expressed in pe-
ripheral nociceptors of dorsal root ganglia (DRGs) and 
primary sensory afferents (Caterina et al., 1997). Besides 
vanilloids, TRPV1 can be activated by noxious heat, 
acidic pH, and endogenous lipid agonists, and sensi-
tized by proinflammatory agents such as bradykinin and 
nerve growth factor (Ramsey et al., 2006). It functions 
as a signal transducer by integration of diverse noxious 
thermal and chemical stimuli (Tominaga et al., 1998; 
Venkatachalam and Montell, 2007). TRPV1 plays a key 
role in pain after inflammation or tissue injury, espe-
cially  in  inflammation-induced  thermal  hyperalgesia 
(Caterina et al., 2000).
TRPV1 is permeable to many cations but predomi-
nantly to calcium when activated (Marsh et al., 1987; 
Caterina et al., 1997). The influx of cations through 
TRPV1 causes membrane depolarization and also initiates 
a cascade of cellular events, including the activation of 
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other ion channels that leads to more depolarization. 
Ultimately, the membrane depolarization reaches a 
threshold that enables action potential generation and 
propagation along the sensory afferents of peripheral 
nociceptors. This leads to the release of a variety of neu-
rotransmitters from the central terminals of the pri-
mary  nociceptors  and  the  activation  of  second-order 
neurons of the dorsal horn. This information will ulti-
mately be perceived in the central nervous system as 
pain (Szallasi and Blumberg, 1999).
Neuronal excitation caused by capsaicin and other 
stimuli is likely subject to control by several negative 
regulatory mechanisms. One such mechanism is medi-
ated by the Kv7 (KCNQ) family of potassium channels, 
of  which  the  coassembly  of  KCNQ2  and  KCNQ3 
forms a major subtype (Wang et al., 1998; Jentsch, 
2000). KCNQ2/3 conducts the so-called M current, a 
low-threshold, slowly activating and noninactivating po-
tassium current found in various central and peripheral 
neurons, including DRG neurons (Wang et al., 1998; 
Passmore et al., 2003). By repolarizing the membrane 
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Transient receptor potential vanilloid 1 (TRPV1) is a ligand-gated nonselective cation channel expressed predomi-
nantly in peripheral nociceptors. By detecting and integrating diverse noxious thermal and chemical stimuli, and 
as a result of its sensitization by inflammatory mediators, the TRPV1 receptor plays a key role in inflammation- 
induced pain. Activation of TRPV1 leads to a cascade of pro-nociceptive mechanisms, many of which still remain 
to be identified. Here, we report a novel effect of TRPV1 on the activity of the potassium channel KCNQ2/3, a 
negative regulator of neuronal excitability. Using ion influx assays, we revealed that TRPV1 activation can abolish 
KCNQ2/3 activity, but not vice versa, in human embryonic kidney (HEK)293 cells. Electrophysiological studies 
showed that coexpression of TRPV1 caused a 7.5-mV depolarizing shift in the voltage dependence of KCNQ2/3 
activation compared with control expressing KCNQ2/3 alone. Furthermore, activation of TRPV1 by capsaicin led 
to a 54% reduction of KCNQ2/3-mediated current amplitude and attenuation of KCNQ2/3 activation. The inhibi-
tory effect of TRPV1 appears to depend on Ca
2+ influx through the activated channel followed by Ca
2+-sensitive de-
pletion  of  phosphatidylinositol  4,5-bisphosphate  and  activation  of  protein  phosphatase  calcineurin.  We  also 
identified physical interactions between TRPV1 and KCNQ2/3 coexpressed in HEK293 cells and in rat dorsal root 
ganglia neurons. Mutation studies established that this interaction is mediated predominantly by the membrane-
spanning regions of the respective proteins and correlates with the shift of KCNQ2/3 activation. Collectively, these 
data reveal that TRPV1 activation may deprive neurons from inhibitory control mediated by KCNQ2/3. Such neu-
rons may thus have a lower threshold for activation, which may indirectly facilitate TRPV1 in integrating multiple 
noxious signals and/or in the establishment or maintenance of chronic pain.
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TOPO expression vector with V5 tag fused in-frame with the   
C terminus. To make TRPV1 truncation mutants TRPV1-N-TM and 
TRPV1-N, a stop codon was introduced after G684 and R433, re-
spectively, by site-directed mutagenesis using the QuickChange 
Site-Directed Mutagenesis kit (Agilent Technologies) according 
to the manufacturer’s instructions.
Antibodies
The following antibodies were obtained from the sources indicated: 
KCNQ2 antibody (ab22897; Abcam), TRPV1 antibody (sc-12498; 
Santa Cruz Biotechnology, Inc.), HA tag antibody (Roche), V5 tag 
antibody (Invitrogen), and flag tag antibody (Sigma-Aldrich).
Transfection and cell culture
Human embryonic kidney (HEK)293 cells were cultured in Dulbec-
co’s modified Eagle’s medium (Invitrogen) supplemented with 10% 
FBS and 1% penicillin-streptomycin in a humidified 5% CO2, 95% 
O2 incubator at 37°C. Cells were transfected using LipofectAMINE 
2000 (Invitrogen) according to the manufacturer’s instructions.
Coimmunoprecipitation and Western blot
HEK293 cells in 10-cm dishes were transiently transfected with 
equal amounts of the expression constructs (totally 10 µg DNA). 
When only a single construct was transfected, pcDNA3.1 vector 
was included to maintain the same final amount of DNA. Cells 
were lysed 48 h after transfection with IP buffer (50 mM Tris 7.5, 
250 mM NaCl, 0.5% NP-40, 0.5% sodium deoxycholate, 2 mM 
EDTA, 0.5 mM DTT, and protease inhibitor cocktail from Sigma-
Aldrich). The cell lysates were then centrifuged to remove cell 
debris, and the antibody used for immunoprecipitation was added 
to the supernatant. After overnight incubation at 4°C with gentle 
agitation, immune complexes were precipitated with protein A or 
protein G agarose beads (Invitrogen), followed by three washes in 
1 ml IP buffer. After the final wash, the pellet was resuspended in 
Laemmli sample buffer, and proteins were resolved by SDS-PAGE 
(4–12% gel) and transferred to polyvinylidene fluoride membrane 
for immunoblot analysis.
Whole cell patch clamp
HEK293 cells were transfected with KCNQ2 and KCNQ3 expres-
sion constructs and with either TRPV1 or an empty vector (as a 
negative control). Cells were also cotransfected with a plasmid 
encoding a GFP reporter (in a 1:10 ratio) to allow identification 
of positively transfected cells for whole cell patch-clamp measure-
ments. 48 h after transfection, whole cell currents were recorded 
at room temperature using the standard patch-clamp technique 
with an amplifier (Axopatch 200B; Axon Instruments), controlled 
with a personal computer using pCLAMP9 software (Axon Instru-
ments). Borosilicate pipettes with a typical resistance of  2–3 MΩ 
were filled with a solution containing (in mM): 125 K-aspartate, 
20 KCl, 10 EGTA, 1 MgCl2, 5 Mg-ATP, and 5 HEPES, with pH 
adjusted to 7.2 with KOH. Extracellular solution contained (in mM): 
140 NaCl, 5 KCl, 2 CaCl2, 1 MgCl2, 10 HEPES, and 5 glucose, with 
pH adjusted to 7.4 with NaOH. KCNQ currents, filtered at 5 KHz 
using the built-in filter of the amplifier, were recorded from a tail 
current protocol where cells were held at 100 mV and clamped 
for 1 s to test potentials between 100 to +60 mV in 10-mV steps, 
followed by a 200-ms tail pulse to 30 mV. In experiments shown 
in Fig. 2, as capsaicin causes TRPV1-mediated inward currents, 
KCNQ2/3 current was not recorded until capsaicin was washed 
off and the holding current returned to pre-capsaicin level, which 
usually took 30–60 s. In experiments shown in Figs. 3 and 4, 
retigabine-  or  capsaicin-evoked  currents  were  recorded  when 
cells were held at 40 mV. In experiments shown in Fig. 4 A, Ca
2+-
free extracellular solution contained (in mM): 140 NaCl, 5 KCl,   
5 EGTA, 1 MgCl2, 10 HEPES, and 5 glucose, with pH adjusted to 
7.4 with NaOH.
back toward the resting membrane potential, the M cur-
rent contributes to the regulation of neuronal subthresh-
old excitability and responsiveness to synaptic input in 
several neuronal systems (Gribkoff, 2003). Mutations in 
KCNQ2 and KCNQ3 have been genetically linked to be-
nign familial neonatal convulsions (Biervert et al., 1998; 
Charlier et al., 1998; Singh et al., 1998). KCNQ2/3 
channel openers retigabine and ICA-27243 exert anti-
convulsant and analgesic activities in a broad range of 
seizure and pain models (Rostock et al., 1996; Blackburn-
Munro and Jensen, 2003). These studies revealed the 
KCNQ2/3 channel as a critical negative regulator of 
neuronal excitability.
Activation  of  TRPV1  leads  to  activation  of  pro- 
nociceptive mechanisms, including neurotransmitter re-
lease (Szallasi and Blumberg, 1999). However, whether 
any  TRPV1  activation-mediated  event  includes  cross-
talk with negative regulatory mechanisms of neuronal 
excitability has not yet been reported. In this study, we 
report on the novel findings of a physical association of 
TRPV1  with  KCNQ2/3  channels  and  suppression  of 
KCNQ2/3 channel activity by coexpression and activa-
tion of TRPV1. These findings imply that repressing the 
negative regulatory mechanism mediated by KCNQ2/3 
channels may be one way in which TRPV1 can facilitate 
its role in pain and establish a hyperexcitable state.
M AT E R I A L S   A N D   M E T H O D S
Chemicals
Capsaicin,  deltamethrin,  and  N-(6-aminohexyl)-5-chloro-1-
naphthalenesulfonamide hydrochloride (W-7) were purchased 
from Sigma-Aldrich. XE991 dihydrochloride was obtained from 
Tocris Bioscience, and phosphatidylinositol 4,5-bisphosphate (PIP2) 
was purchased from Cayman Chemical. Retigabine, A-425619 
[1-isoquinolin-5-yl-3-(4-trifluoromethyl-benzyl)-urea], and com-
pound A1 ((±)-exo-2-bicyclo[2.2.1]hept-2-yl-N-(2-isopropyl-4-oxo-
quinazolin-3(4H)-yl)acetamide) were synthesized in-house according 
to published methods (Blackburn-Munro et al., 2005; Gomtsyan 
et al., 2005; Scanio et al., 2010). BTC-AM dye and cell culture re-
agents were obtained from Invitrogen. Fluo-3 AM dye was pur-
chased from Molecular Devices.
Cloning
To generate V5-tagged human KCNQ2 (available from GenBank/
EMBL/DDBJ under accession no. NM_172107), the coding se-
quence of a full-length KCNQ2 cDNA clone obtained from Ori-
Gene was amplified by PCR and sequence confirmed and cloned 
into the pcDNA3.1/V5-His TOPO expression vector (Invitrogen) 
with V5 and His tags in-frame with the C terminus of KCNQ2. 
To  clone  flag-tagged  human  KCNQ3  (GenBank  accession  no. 
NM_004519), the coding sequence of KCNQ3 was released from a 
cDNA clone from OriGene and cloned into the EcoRI and XbaI 
sites of pcDNA3.1/Zeo(+) expression vector. A flag tag sequence 
was subsequently amplified by PCR and cloned in-frame with the 
C terminus of KCNQ3. The cloning of human TRPV1 with an   
N-terminal HA tag was described previously (Vos et al., 2006).
To generate KCNQ2 truncation mutants, coding sequences for 
corresponding portions of KCNQ2 (KCNQ2-TM-C, A97-K872; 
KCNQ2-N-TM, M1-L318; KCNQ2-TM, A97-L318; KCNQ2-C, K319- 
K872) were amplified by PCR and cloned into the pcDNA3.1/V5-His   Zhang et al. 343
2.5 K-gluconate, 3.6 Ca-gluconate, 2 MgSO4, and 0.1 Ouabain) to 
remove unloaded dye. The wash buffer was discarded and the 
cells were incubated in 100 µl of assay buffer before loading onto 
a fluorometric imaging plate reader (FLIPR) system (Molecular 
Devices). Compounds to be assayed were added to the cells in 
100 µl of assay buffer along with 6 mM TlNO3 (Sigma-Aldrich) 
and 10 mM K2SO4 to initiate Tl
+ influx FLIPR signals. Fluors were 
excited using the 488-nm line of an argon laser, and emission was 
filtered using a 540 ± 30–nm bandpass filter. Fluorescent signals 
were recorded for 3 min.
The Ca
2+ influx assay was performed using the fluorescent 
calcium-chelating dye fluo-3, essentially as described previously 
(El Kouhen et al., 2005).
R E S U LT S
KCNQ2/3 activation has no effect on TRPV1 activity 
measured by calcium influx assay
We first used FLIPR-based ion influx assays to explore 
any possible functional interaction between TRPV1 and 
KCNQ2/3 channels. Ca
2+ influx assay is a well-established 
approach to study TRPV1 activity (El Kouhen et al., 2005), 
so we used this assay to assess possible effects of KCNQ2/3 
on TRPV1. We transfected HEK293 cells with KCNQ2/3, 
TRPV1, or KCNQ2/3 and TRPV1 together and evalu-
ated their responses to retigabine, a KCNQ channel 
opener, and to the TRPV1 agonist capsaicin. Ca
2+ is not 
permeable through KCNQ2/3, so cells transfected with 
KCNQ2/3 alone showed, as expected, no Ca
2+ influx 
upon treatment with 10 µM retigabine or 0.1 µM capsa-
icin (Fig. 1 A). In contrast, HEK293 cells expressing 
TRPV1 respond to stimulation by 0.1 µM capsaicin with 
a dramatic increase in Ca
2+ influx signal but show no 
response  to  10  µM  retigabine.  This  TRPV1-mediated 
Ca
2+ influx can be blocked by 1 µM of the TRPV1 antago-
nist A-425619 (El Kouhen et al., 2005). In cells express-
ing both TRPV1 and KCNQ2/3, a dramatic increase in 
Data analysis
The  voltage-dependent  activation  was  determined  from  peak   
tail  currents  and  fitted  with  the  Boltzmann  equation:  G  =   
(Gmax  Gmin)/(1 + exp[(V  V1/2)/k]) + Gmin, where Gmax and 
Gmin are the maximum and minimum conductance, respectively. 
Half-activation voltage (V1/2) and slope factor (k) were then de-
termined. Average data are presented as mean ± SEM. Statisti-
cal significance was determined using Student’s t test.
Immunofluorescence
Male Sprague–Dawley rats (200–350 g; Charles River) were deeply 
anesthetized with CO2 and perfused through the aorta with buff-
ered saline, followed by 10% formalin. DRGs were dissected and 
embedded in OCT on dry ice. DRG tissues were cut into 20-µm 
frozen sections with a cryostat and thaw-mounted onto superfrost 
glass slides (VWR International). DRG sections were fixed and 
permeabilized with 4% paraformaldehyde for 10 min. After rins-
ing twice in PBS, the sections were incubated in blocking buffer 
(2% FBS and 2% BSA in PBS) for 30 min to reduce nonspecific 
binding.  The  sections  were  then  incubated  with  rabbit  anti-
KCNQ2 antibody and goat anti-TRPV1 antibody diluted in the 
blocking buffer for 2 h. After incubating with primary antibodies, 
the slides were washed once in PBS with 0.25% NP-40 followed by 
twice in PBS. The slides were then incubated with Alexa Fluor 
488–conjugated donkey anti–rabbit IgG (Invitrogen) and Alexa 
Fluor 555–conjugated donkey anti–goat IgG (Invitrogen) diluted 
in blocking buffer (1:200 dilution) for 1 h. After washing once in 
PBS with 0.25% NP-40 followed by twice in PBS, the slides were 
mounted  (Vectashield;  Vector  Laboratories)  for  observation 
using a laser-scanning confocal imaging system (LSM 5 PASCAL; 
Carl Zeiss).
Ion influx assays
The thallium (Tl
+) influx assay was performed essentially as de-
scribed previously (Weaver et al., 2004), with some modifications. 
Cells were seeded in 96-well black-walled, clear-bottomed poly-d-
lysine–coated plates (BD) at a density of 10
5 cells per well 24 h be-
fore the assay. On the assay day, BTC-AM dye was loaded into the 
cells by replacing the cell culture medium with 100 µl/well of 4 µM 
dye in DPBS. Dye loading was allowed to proceed for 2 h at room 
temperature, and then cells were washed twice in 100 µl/well of assay 
buffer (in mM: 10 HEPES, pH 7.3, 5 glucose, 140 Na-gluconate, 
Figure  1.  Functional  interac-
tions  between  KCNQ2/3  and 
TRPV1 channels as revealed by 
ion influx assays. (A) KCNQ2/3 
activation does not affect TRPV1 
activity  as  measured  by  Ca
2+ 
influx assay. HEK293 cells were 
transfected  with  KCNQ2/3, 
TRPV1, or KCNQ2/3 and TRPV1 
together,  and  Ca
2+  influx  into 
these cells in response to 10 µM 
retigabine,  0.1  µM  capsaicin, 
and  1  µM  A-425619,  as  indi-
cated, was measured by FLIPR-
based  Ca
2+  influx  assay.  Ca
2+ 
influx in cells expressing TRPV1 
and KCNQ2/3 with mock treat-
ment was set at 100. Normalized 
Ca
2+ influx values expressed as mean ± SEM of six separate assays are shown. (B) Activation of TRPV1 suppresses KCNQ2/3 activity in Tl
+ 
influx assay. HEK293 cells were transfected with either KCNQ2/3, TRPV1, or KCNQ2/3 and TRPV1 together, and Tl
+ influx into these 
cells in response to 10 µM retigabine, 0.1 µM capsaicin, 10 µM XE991, 1 µM A-425619, and 10 µM compound A1, in combinations as 
indicated, was measured by FLIPR-based Tl
+ influx assay. Normalized Tl
+ influx signals (expressed as mean ± SEM of six separate assays) 
relative to those from cells expressing TRPV1 and KCNQ2/3 with mock treatment are shown.344 TRPV1 activation suppresses the KCNQ2/3 channel
pretreated cells with 1 µM A-425619 to inhibit capsaicin-
mediated TRPV1 activation, the combined Tl
+ influx 
remained at the same level and was now sensitive to 
blockade by XE991 (Fig. 1 B). This indicates that block-
ing TRPV1 activation by A-425619 may relieve the in-
hibitory effect caused by TRPV1 activation on KCNQ2/3 
activity and hence allow Tl
+ influx driven by KCNQ2/3 
to  contribute  to  the  signal  observed  in  cells  coex-
pressing both channels. In summary, data from the Tl
+ 
influx assay suggest that TRPV1 activation may suppress 
KCNQ2/3 activity.
Coexpression of TRPV1 shifted the voltage-dependent 
activation of the KCNQ2/3 channel
To confirm and extend our observations in ion influx 
assays,  we  turned  to  electrophysiological  studies  to 
evaluate  functional  interactions  between  TRPV1  and 
KCNQ2/3 in more detail. First, a possible effect of co-
expression of TRPV1 on the KCNQ2/3 channel prope  r-
ties was studied. Whole cell patch-clamp experiments 
were  performed  on  HEK293  cells  expressing  the 
KCNQ2/3 channel alone or coexpressed with TRPV1 
(Fig. 2, A and B). The V1/2 of voltage-dependent activa-
tion for the KCNQ2/3 channel when expressed alone 
was 22.0 ± 0.6 mV (n = 11). The V1/2 value was signifi-
cantly shifted by +7.5 mV to 14.5 ± 0.6 mV (n = 11; 
P < 0.0001) in cells coexpressing TRPV1 and KCNQ2/3 
together (Fig. 2 C). This indicates that coexpression of 
TRPV1 leads to a depolarizing shift of the voltage de-
pendence of KCNQ2/3 activation.
Activation of TRPV1 by capsaicin suppressed KCNQ2/3 
channel activity
We next examined any possible effects of TRPV1 activa-
tion on KCNQ2/3 channel activity in cells coexpressing 
KCNQ2/3 and TRPV1. 3 µM capsaicin was applied to 
the cells for 5–10 s. Once TRPV1 was activated, capsa-
icin was washed off, and the KCNQ2/3 current was then 
recorded (Fig. 2 B). Capsaicin treatment did not change 
the V1/2 of voltage-dependent activation for KCNQ2/3 
any further than observed when the channels were co-
expressed without TRPV1 activation (Fig. 2 E). However, 
KCNQ2/3-mediated current amplitude was reduced by 
54% upon treatment with capsaicin (Fig. 2, B and D). 
To exclude the possibility of a direct action of capsaicin 
on KCNQ2/3 channels, we examined the effect of capsai-
cin on cells expressing KCNQ2/3 alone. 3 µM capsaicin 
had no effect on KCNQ2/3 current amplitude (Fig. 2, A 
and D) or V1/2 of voltage-dependent activation (Fig. 2 F), 
indicating that the effect of capsaicin on KCNQ2/3 is 
likely through activation of TRPV1.
Activation of TRPV1 suppressed the activation  
of KCNQ2/3 channels by retigabine
Because  coexpression  and  activation  of  TRPV1  have 
profound effects on the KCNQ2/3 channel, we next   
Ca
2+ influx was observed when cells were treated with 
0.1 µM capsaicin but not with 10 µM retigabine, thus re-
vealing a TRPV1-mediated Ca
2+ influx signal. When these 
cells were treated with 10 µM retigabine initially for 3 min 
and then treated with 0.1 µM capsaicin, the TRPV1-
mediated Ca
2+ influx was not affected by retigabine-
mediated  KCNQ2/3  activation  (Fig.  1  A).  In  addition,   
the ability of A-425619 to block the capsaicin-mediated 
activation of TRPV1 appeared to be unaffected by the 
presence of KCNQ2/3 and its opener retigabine. Collec-
tively, these data indicate that activation of KCNQ2/3 
does not affect the activity of TRPV1.
Activated TRPV1 inhibits KCNQ2/3 channel activation 
measured by Tl
+ influx assay
A  Tl
+  influx  FLIPR  assay  has  been  used  to  measure 
KCNQ2 activity (Weaver et al., 2004), so we used a simi-
lar assay to investigate the effect of TRPV1 activation   
on KCNQ2/3 activity. HEK293 cells transfected with 
KCNQ2/3 alone responded to activation by 10 µM reti-
gabine with over a fourfold increase in Tl
+ influx signal, 
which can be blocked by pretreatment with 10 µM 
XE991, a KCNQ-specific blocker (Fig. 1 B). In contrast, 
0.1 µM capsaicin had no effect on KCNQ2/3 activity, as 
expected. As a nonselective cation channel, TRPV1 can 
conduct an influx of Tl
+
. Thus, cells expressing TRPV1 
alone  showed  an  increase  in  Tl
+  influx  signal  upon 
treatment with 0.1 µM capsaicin, which can be blocked 
by A-425619. However, 10 µM retigabine showed no 
effect on the TRPV1 channel, as expected (Fig. 1 B).
We then tested HEK293 cells expressing both TRPV1 
and KCNQ2/3. When these cells were treated with ei-
ther 10 µM retigabine or 0.1 µM capsaicin, we observed 
KCNQ2/3- or TRPV1--mediated Tl
+ influx increase to a 
similar level (Fig. 1 B). However, when the cells were 
treated with retigabine and capsaicin together, we ob-
served a combined signal at a level just equivalent to 
that activated by either retigabine or capsaicin alone. 
The lack of expected additive effects on the Tl
+ influx 
signal is not a result of saturation of the fluorescence 
signal because other KCNQ2/3 openers that we have 
assayed, such as compound A1, can lead to a Tl
+ influx 
signal two- to threefold larger than that caused by 10 µM 
retigabine (Fig. 1 B). Instead, the results suggested that 
either the KCNQ2/3- or TRPV1-driven signal may be 
attenuated. Our data from the Ca
2+ influx assay sug-
gested  that  activation  of  KCNQ2/3  has  no  effect  on 
TRPV1  activity,  so  the  combined  Tl
+  influx  signal  is 
likely driven only by TRPV1 activity, and the KCNQ2/3-
driven Tl
+ influx could be inhibited. Consistent with 
this,  when  TRPV1  and  KCNQ2/3  coexpressing  cells 
were treated with 10 µM XE991 before adding retiga-
bine and capsaicin, there was no significant drop in the 
combined Tl
+ influx (Fig. 1 B), indicating that this sig-
nal is primarily driven by TRPV1 activation that is not 
sensitive to blockade by XE991. Furthermore, when we   Zhang et al. 345
by  activation  of  TRPV1.  First,  when  the  same  com-
pound application scheme was applied to cells that 
expressed KCNQ2/3 alone, no inward current was ob-
served when capsaicin was applied, owing to the lack of 
TRPV1 expression. In this instance, the reapplication of 
retigabine could elicit an outward current with similar 
amplitude (90%) to that of the first retigabine applica-
tion (Fig. 3, B and D). Second, when 1 µM of the TRPV1 
antagonist A-425619 (El Kouhen et al., 2005) was ap-
plied to cells expressing both KCNQ2/3 and TRPV1, no 
inward current was observed when cells were treated 
with capsaicin. Under such conditions, activation of the 
KCNQ2/3 channel was not suppressed and an outward 
current with similar amplitude (82%) to the initial current 
was observed after the reapplication of retigabine (Fig. 3, 
C and D). These data indicate that activation of TRPV1 
by capsaicin leads to the suppression of KCNQ2/3 cur-
rents evoked by retigabine.
examined whether activation of TRPV1 affects the ability 
of the KCNQ opener retigabine to activate KCNQ2/3 
channels. At a holding potential of 40 mV, the appli-
cation  of  10  µM  retigabine  to  cells  that  coexpressed 
KCNQ2/3 and TRPV1 channels elicited an outward 
current,  which  is  attributed  to  the  activation  of  the 
KCNQ2/3 channel (Fig. 3 A). Subsequent application 
of 1 µM capsaicin elicited a large inward current be-
cause of the activation of the TRPV1 channel. However, 
after capsaicin was washed off, the reapplication of   
10 µM retigabine elicited a much smaller outward cur-
rent, with current amplitude reduced by 75% com-
pared  with that from the first retigabine application 
(Fig. 3, A and D). This indicates that the enhancement 
of KCNQ2/3 currents by retigabine was attenuated by 
activation of TRPV1.
We conducted two additional experiments to confirm 
that the inhibition of KCNQ2/3 activation was caused 
Figure 2.  Effects of coexpression and activation of TRPV1 on the KCNQ2/3 channel. HEK293 cells expressing KCNQ2/3 alone or 
KCNQ2/3 and TRPV1 together were exposed to either buffer (as a control) or 3 µM capsaicin, and then the reagents were washed off. 
KCNQ2/3 currents were recorded by using 1,000-ms voltage pulses ranging from 100 to +60 mV in 10-mV increments from a holding 
potential of 100 mV. (A) Representative current traces for cells expressing KCNQ2/3 alone are shown. (B) Representative current 
traces for cells expressing KCNQ2/3 and TRPV1 together are shown. (C) The voltage-dependent activation curves for KCNQ2/3 coex-
pressed with or without TRPV1 were plotted. V1/2 and slope factor k for KCNQ2/3 alone (n = 11) were 22.0 ± 0.6 mV and 9.3 ± 0.6 mV, 
and for TRPV1/KCNQ2/3 (n = 11) were 14.5 ± 0.6 mV and 9.9 ± 0.6 mV. (D) Current amplitudes (measured at +20 mV from a holding 
potential of 100 mV) retained as a percentage of controls upon capsaicin treatment are shown. In cells expressing KCNQ2/3 alone, 
97 ± 6% of current amplitude was retained upon treatment with capsaicin (n = 6). In cells coexpressing KCNQ2/3 and TRPV1 together, 
46 ± 9% of KCNQ2/3 current amplitude was retained upon treatment with capsaicin (n = 9). (E) In cells coexpressing KCNQ2/3 and 
TRPV1, the voltage-dependent activation curves for KCNQ2/3 with or without exposure to capsaicin were plotted. V1/2 and slope factor k in 
control (n = 9) were 14.0 ± 0.7 mV and 9.7 ± 0.7 mV, and upon capsaicin treatment (n = 9) were 14.6 ± 1.3 mV and 10.2 ± 1.2 mV. 
(F) The voltage-dependent activation curves for KCNQ2/3 with or without exposure to capsaicin in cells expressing KCNQ2/3 alone 
were plotted. V1/2 and slope factor k in control (n = 6) were 22.4 ± 0.9 mV and 9.2 ± 0.8 mV, and upon capsaicin treatment (n = 6) were 
21.8 ± 0.8 mV and 9.0 ± 0.7 mV.346 TRPV1 activation suppresses the KCNQ2/3 channel
protein phosphatase calcineurin, or it may deplete PIP2 
in the cell membrane via Ca 
2+-induced PLC-mediated 
hydrolysis;  all  three  of  these  possibilities  have  been   
reported to contribute to KCNQ channel inhibition   
(Marrion, 1996; Gamper and Shapiro, 2003; Zhang et al., 
2003). To assess whether PIP2 depletion may mediate 
the  inhibitory  effect  of  TRPV1  on  KCNQ2/3,  we  re-
peated the experiment shown in Fig. 3 A to study the 
effect of TRPV1 by including 25 µM PIP2 in the internal 
pipette solution. In contrast to the observation in Fig. 3 A, 
the presence of excess PIP2 relieved the inhibition of 
KCNQ2/3 channel by TRPV1 activation, and the reappli-
cation of 10 µM retigabine elicited an outward current 
with  similar  amplitude  (83%)  to  the  first  retigabine-
evoked current (Fig. 4, B and E). We then studied possi-
ble  involvement  of  calmodulin  in  a  similar  assay  by 
in  cluding 200 µM of the calmodulin inhibitor W-7 in the 
internal solution (Wu et al., 2005). The addition of W-7 
failed to prevent the inhibitory effect of TRPV1 activa-
tion, and a repressed retigabine-evoked current (21% of 
control) was observed after TRPV1 activation (Fig. 4, C 
and E). To study possible involvement of calcineurin, we 
added 1 µM of the calcineurin inhibitor deltamethrin in 
the internal solution (Wu et al., 2005). Similar to the 
effect of PIP2 addition, deltamethrin relieved the inhib-
itory effect of TRPV1 activation, and a robust retigabine-
evoked current (90% of control) was observed after 
TRPV1 activation (Fig. 4, D and E).
Activation of TRPV1 in the absence of extracellular Ca
2+ 
had minimal effect on KCNQ2/3 channel activation
The activated TRPV1 channel conducts the influx of 
several different cations but predominantly of Ca
2+. To 
assess  whether  the  inhibitory  effect  of  TRPV1  on 
KCNQ2/3  depends  on  Ca
2+  influx  through  the  acti-
vated channel, we repeated the experiment shown in 
Fig. 3 A to study the effect of TRPV1 in the absence of 
extracellular Ca
2+. Whole cell currents from HEK293 
cells expressing both TRPV1 and KCNQ2/3 were re-
corded in a Ca
2+-free extracellular solution when the 
cells were held at 40 mV. The application of 10 µM 
retigabine followed by the application of 1 µM capsai-
cin elicited a KCNQ2/3-mediated outward current and 
a subsequent TRPV1-mediated inward current. However, 
in contrast to the observation in Fig. 3 A, the reapplica-
tion of 10 µM retigabine elicited an outward current 
with 77% of the initial retigabine-evoked current (Fig. 4, 
A and E). The significant relief of an inhibitory effect on 
KCNQ2/3 activity in the absence of extracellular Ca
2+ 
suggests that Ca
2+ influx through the activated TRPV1 
channel is required to mediate the inhibitory effect.
Mechanisms for suppression of KCNQ2/3 channels by Ca
2+ 
influx through activated TRPV1 channels
TRPV1-mediated Ca
2+ influx may inhibit KCNQ2/3 ac-
tivity by several possible mechanisms. The excess Ca
2+ 
may either bind to calmodulin or activate Ca
2+-sensitive 
Figure  3.  Activation  of  TRPV1 
suppressed the activation of the 
KCNQ2/3 channel by retigabine. 
(A)  Whole  cell  currents  from 
HEK293  cells  expressing  both 
TRPV1 and KCNQ2/3 were re-
corded  when  voltage  was  held 
at  40  mV.  Compounds  were 
applied  to  cells  sequentially  as 
indicated:  10  µM  retigabine,   
1 µM capsaicin, and then 10 µM 
retigabine.  A  typical  current 
trace recorded is shown. (B) The   
same  experimental  scheme  as 
described in A was used, except 
cells expressing KCNQ2/3 alone   
were used instead. (C) The same 
experimental  scheme  as  de-
scribed  in  A  was  used,  except 
1  µM  A-425619  and  capsaicin 
were coapplied to cells express-
ing  both  TRPV1  and  KCNQ2/ 
3  to  block  TRPV1  activation.   
(D) The average current ampli-
tude evoked by the second retiga-
bine application as a percentage 
of the control, from the first re-
tigabine  application,  in  each  of 
these three cases (shown in a–c) 
is plotted in a bar graph: case a,   
25 ± 10% (n = 10); case b, 90 ± 3% 
(n = 4); case c, 82 ± 10% (n = 7).  Zhang et al. 347
HEK293 cells. Immunoprecipitation of either KCNQ2 
or KCNQ3 by anti-V5 or anti-flag antibody, respectively, 
resulted in coimmunoprecipitation of TRPV1 (Fig. 5 B). 
Reciprocally, both KCNQ2 and KCNQ3 were coim-
muno  precipitated  with  TRPV1,  indicating  a  physical 
interaction of TRPV1 with both KCNQ subtypes. We 
also observed under these conditions a physical interac-
tion between KCNQ2 and KCNQ3, by coimmunopre-
cipitation. This interaction appears to be more robust 
than that between TRPV1 and KCNQ subtypes, based 
on band intensity (Fig. 5 B), implying that KCNQ2 and 
KCNQ3 can still form an intact heterotetrameric chan-
nel in addition to their association with TRPV1.
The association of TRPV1 and KCNQ2 is mapped to their 
respective six-transmembrane domain–containing regions
To investigate which region of the KCNQ2 channel is 
responsible for the physical association with TRPV1, 
various KCNQ2 truncations were made and their inter-
actions with TRPV1 were assessed by coimmunoprecipi-
tation. The KCNQ2 channel has a central region with six 
transmembrane helices flanked by a short N-terminal 
region and a relatively longer C terminus. We made sev-
eral KCNQ2 deletion constructs that, when expressed, 
produced proteins containing only one or two of these 
three regions (Fig. 6 A). It was observed that KCNQ2 
deletion mutants with a truncation in either the N ter-
minus or the C terminus could efficiently coimmuno-
precipitate with TRPV1 (Fig. 6 A). Further truncation 
Coimmunoprecipitation of TRPV1 with KCNQ2 and 
KCNQ2/3 in mammalian cells
The  functional  interactions  between  KCNQ2/3  and 
TRPV1  channels  led  us  to  explore  whether  they  may 
physically associate with each other. We first determined 
whether TRPV1 has a physical interaction with KCNQ2 
by coimmunoprecipitation. HA-tagged TRPV1 was ex-
pressed in HEK293 cells either alone (negative control) 
or together with V5-tagged KCNQ2. The expression of 
TRPV1 could be detected by Western blot analysis of 
products immunoprecipitated with TRPV1 antibody as 
two major bands (Fig. 5 A), which represent different 
glycosylated forms of TRPV1 (Jahnel et al., 2001; Vos   
et al., 2006). When KCNQ2 antibody was used in the 
immunoprecipitation, we observed that the lower band, 
which represents the less glycosylated form of TRPV1, 
can be coimmunoprecipitated with KCNQ2 when both 
were expressed, but not when TRPV1 alone was expressed 
(Fig. 5 A). In reciprocal experiments, when TRPV1 anti-
body  was  used  in  immunoprecipitation,  KCNQ2,  de-
tected by V5 antibody, could be coimmunoprecipitated 
along with TRPV1 only when they were coexpressed in 
HEK293 cells (Fig. 5 A). These data revealed a physical 
interaction between KCNQ2 and TRPV1.
We also investigated whether TRPV1 has a physical 
interaction with the heterotetrameric channel formed 
by KCNQ2 and KCNQ3 in similar coimmunoprecipita-
tion studies. HA-tagged TRPV1 along with V5-tagged 
KCNQ2  and  flag-tagged  KCNQ3  were  expressed  in 
Figure  4.  Mechanisms  of  sup-
pression of retigabine-mediated 
KCNQ2/3  activation  caused  by 
TRPV1  activation.  Whole  cell   
currents  from  HEK293  cells 
expressing  both  TRPV1  and 
KCNQ2/3 were recorded when 
voltage  was  held  at  40  mV. 
Compounds  were  applied  to 
cells  sequentially  as  indicated: 
10 µM retigabine, 1 µM capsai-
cin, and then 10 µM retigabine. 
A typical current trace (A) with 
a Ca
2+-free extracellular solution 
used,  (B)  with  25  µM  PIP2, 
(C) with 200 µM W-7, and (D) 
with 1 µM deltamethrin added in 
the internal solution. (E) The av-
erage current amplitudes evoked 
by the second retigabine appli-
cation  as  a  percentage  of  the 
control from the first retigabine 
application  in  these  cases  were 
plotted in a bar graph: Ca
2+-free 
(-Ca
2+), 77 ± 6% (n = 6); PIP2, 
83 ± 4% (n = 9); W-7, 21 ± 11% 
(n = 7); deltamethrin (delta), 90 ± 
7% (n = 8).348 TRPV1 activation suppresses the KCNQ2/3 channel
activation for the KCNQ2/3 channel coexpressing with 
TRPV1-N-TM was 16.6 ± 0.9 mV (n = 8), a significant 
shift of +6.2 mV compared with the value when KCNQ2/3 
was expressed alone (22.8 ± 0.9 mV; n = 6; P < 0.001; 
Fig. 6 C). This result establishes a correlation for the 
physical interaction between KCNQ2/3 and TRPV1, and 
the functional effect of a depolarized shift in the voltage 
dependence of KCNQ2/3 activation.
Physical interaction and colocalization of TRPV1  
with KCNQ2 in DRG neurons
To investigate whether the interaction between TRPV1 
and KCNQ2 channels has a physiological relevance, we 
turned to DRG neurons in which the expression of both 
channels has been reported (Passmore et al., 2003; Vos   
et al., 2006). Rat DRGs were dissected, and the physical 
interaction between TRPV1 and KCNQ2 was investigated 
using  coimmunoprecipitation.  With  anti-KCNQ2  anti-
body, a significant amount of KCNQ2 was precipitated 
from protein extracts prepared from whole rat DRGs, 
and TRPV1 was coprecipitated along with KCNQ2, as re-
vealed by Western blot analysis (Fig. 7 A). This indicates 
a physical interaction between TRPV1 and KCNQ2 in 
DRGs, in addition to that observed when the two pro-
teins are heterologously coexpressed in HEK293 cells.
To further localize the expression of TRPV1 and 
KCNQ2, we prepared slides of rat DRG sections and 
probed for their expression on DRG neurons by immuno-
fluorescent staining. To assess antibody specificity, we 
performed Western blot analyses on HEK293 cells ex-
pressing either KCNQ2 or TRPV1 and detected a protein 
band specific to each of them with the corresponding 
antibody  (Fig.  7  B).  When  anti-TRPV1  antibody  was 
used in immunostaining, a robust staining on small- and   
medium-sized DRG neurons was observed, whereas   
revealed that the KCNQ2 six-transmembrane domain–
containing region alone still retained full capacity for 
physical interaction with TRPV1. However, the C-terminal 
region of KCNQ2, although expressed as robustly as the 
full-length KCNQ2, loses significant ability to interact 
with  TRPV1.  Collectively,  these  data  suggest  that  the 
central, six-transmembrane domain–containing region 
of KCNQ2 mediates its association with TRPV1.
We  also  mapped  which  region  of  TRPV1  mediates   
its association with KCNQ2 using the same strategy. The   
N terminus alone and the truncated TRPV1 lacking the 
C-terminal region expressed successfully (Fig. 6 B). How-
ever, the central region of TRPV1 containing only the six- 
transmembrane domain or the C-terminal region failed   
to express. Using the truncation constructs that showed 
successful expression, it was observed that TRPV1 without 
its C-terminal region coimmunoprecipitates with KCNQ2 
as efficiently as the full-length TRPV1, whereas the con-
struct expressing just the N terminus of TRPV1 appears to 
be relatively poor at interacting with KCNQ2 (Fig. 6 B). 
These  data  suggest  that  the  central  six-transmembrane   
domain–containing region of TRPV1 may play a major 
role in mediating the interaction with KCNQ2.
The shift of the voltage-dependent activation of the  
KCNQ2/3 channel correlates with its physical  
association with TRPV1
To  explore  whether  the  physical  association  between 
TRPV1 and KCNQ2/3 has any effect on KCNQ2/3 chan-
nel activity, we studied the truncated TRPV1 lacking the 
C-terminal region (TRPV1-N-TM), which retains physical 
interaction with KCNQ2 but loses the ability to function as 
an ion channel. Whole cell patch-clamp experiments were 
performed on HEK293 cells coexpressing the KCNQ2/3 
channel and TRPV1-N-TM. The V1/2 of voltage-dependent 
Figure  5.  TRPV1  coimmunoprecipitates  with  KCNQ2 
and  KCNQ2/3  in  HEK293  cells.  (A)  V5-tagged  KCNQ2 
(KCNQ2-V5) and HA-tagged TRPV1 (TRPV1-HA) in the 
indicated combinations were transiently transfected into 
HEK293  cells.  Western  blot  (WB)  of  products  immuno-
precipitated  (IP)  by  the  indicated  antibodies  is  shown. 
When KCNQ2 is specifically immunoprecipitated in cells co-
expressing both proteins, TRPV1 was found to coimmuno-
precipitate  with  KCNQ2  (bottom  panel  of  top  figure).   
Likewise, when the TRPV1 protein is specifically immuno-
precipitated from cells coexpressing both proteins, KCNQ2 
was found to coimmunoprecipitate with TRPV1 (bottom   
panel of bottom figure). (B) HEK293 cells were trans-
fected with TRPV1-HA, KCNQ2-V5, and flag-tagged KCNQ3. 
Immuno  precipitation  of  any  one  of  these  ion  channel 
proteins by antibody recognizing its respective tag coim-
munoprecipitates both of the other two channel proteins. 
Western blots shown are representative of experiments re-
peated at least three times.  Zhang et al. 349
between  these  different  classes  of  ion  channels  is  a 
novel finding.
The most significant observation from our study is the 
functional interaction between TRPV1 and KCNQ2/3. 
We  did  not  observe  any  functional  consequence  on 
TRPV1 as a result of association with KCNQ2/3. How-
ever, the coexpression and activation of TRPV1 signifi-
cantly affect the KCNQ2/3 channel in three respects. 
First, the coexpression of TRPV1 changes the gating of 
the KCNQ2/3 channel, shifting the V1/2 of activation to 
more depolarized potentials, thus raising the voltage 
threshold for activation. This change in the activation 
curve is not likely caused by different expression levels 
of KCNQ2/3, as indicated by the similar band intensity 
observed in Western blot analysis of KCNQ channel ex-
pression when coexpressed with or without TRPV1 
(Fig. 5 A). Second, TRPV1 activation by capsaicin pro-
foundly  inhibits  KCNQ2/3-mediated  current  ampli-
tude, although there is no significant further shift of the 
almost no specific staining was observed in large DRG 
neurons (Fig. 7 C). For KCNQ2, a significant signal was 
observed in small- and medium-sized DRG neurons. In 
addition, there was relatively weak staining in large DRG 
neurons (Fig. 7 C). The immunostaining of TRPV1 and 
KCNQ2 was colocalized in small- and medium-sized DRG 
neurons, indicating coexpression of these two channels.
D I S C U S S I O N
TRPV1  activation  plays  a  key  role  in  inflammation- 
induced pain in response to diverse noxious stimuli, and 
its activation leads to a series of complex events that 
contribute to this role. Here, we report the novel find-
ing of a physical and functional association between 
TRPV1 and the potassium channel KCNQ2/3. To our 
knowledge,  although  several  interactions  with  other 
proteins  have  been  identified  for  either  TRPV1  or 
KCNQ channels, a physical and functional interaction 
Figure 6.  The KCNQ2 and TRPV1 interaction is predominantly dependent on their respective transmembrane domains and correlates 
with the shift of KCNQ2/3 activation. (A) KCNQ2 full-length (KCNQ2-full) or several truncation mutants lacking one or two of its three 
regions (the N terminus [N], central region with six transmembrane domains [TM], and the C terminus [C]) were transiently cotrans-
fected into HEK293 cells with full-length TRPV1 (TRPV1-full). KCNQ2 proteins were immunoprecipitated by anti-V5 antibody, and the 
coprecipitation of full-length TRPV1 was detected by anti-TRPV1 antibody in Western blot analysis. The expression of KCNQ2 mutants 
is shown in the top panel, and coprecipitation of TRPV1 is shown in the bottom panel. (B) In the reciprocal experiment, full-length or 
truncated TRPV1 was coexpressed in HEK293 cells with full-length KCNQ2, and coimmunoprecipitation of KCNQ2 was investigated. 
Western blots shown are representative of experiments repeated at least twice. (C) KCNQ2/3 currents were recorded on HEK293 cells 
expressing KCNQ2/3 alone or KCNQ2/3 and TRPV1-N-TM together, and the voltage-dependent activation curves for KCNQ2/3 were 
plotted. V1/2 and slope factor k for KCNQ2/3 alone (n = 6) were 22.8 ± 0.9 mV and 8.5 ± 0.8 mV, and for KCNQ2/3+TRPV1-N-TM 
(n = 8) were 16.6 ± 0.9 mV and 9.5 ± 0.8 mV.350 TRPV1 activation suppresses the KCNQ2/3 channel
region of KCNQ channels has binding sites for PIP2, 
and the activation of the channels requires a certain 
level of PIP2 in the cell membrane (Delmas and Brown, 
2005). PIP2 hydrolysis caused by the stimulation of sev-
eral G protein–coupled receptors, for example by spe-
cific muscarinic acetylcholine receptors, is a common 
mechanism for these receptors to inhibit KCNQ chan-
nels (Zhang et al., 2003). Similarly, Ca
2+ influx through 
TRPV1 has been reported to cause depletion of PIP2 
(Liu et al., 2005), which may lead to the inhibition of 
KCNQ2/3 channel activity. Calcineurin (protein phos-
phatase 2B) can be activated by a rise in intracellular 
Ca
2+ and has been shown to inhibit KCNQ channels in 
sympathetic neurons (Marrion, 1996; Klee et al., 1998). 
It  has  been  reported  that  TRPV1  activation  down- 
regulates voltage-gated calcium channels by dephosphory-
lation through Ca
2+-dependent activation of calcineurin 
(Wu et al., 2005). It is possible that a similar calcineurin-
dependent mechanism may be involved in KCNQ2/3 
inhibition by TRPV1. In contrast, assay in the presence 
of the calmodulin inhibitor revealed no involvement of 
calmodulin in this process, although Ca
2+ binding to 
calmodulin  has  been  reported  as  a  mechanism  of 
KCNQ2/3 channel inhibition (Gamper and Shapiro, 
2003).  In  summary,  it  seems  that  inhibition  of  the 
KCNQ2/3 channel by Ca
2+ influx through TRPV1 may 
involve contributions from two mechanisms. The ex-
tent to which each of these mechanisms contributes in 
vivo remains to be determined and may vary depending 
on the site of TRPV1 and KCNQ channel coexpression, 
as well as on specific physiological or pathophysiologi-
cal stimuli.
The physical association between TRPV1 and KCNQ 
channels was evident by coimmunoprecipitation. Although 
only the less glycosylated form of TRPV1 coprecipi-
tated with KCNQ, the cell surface localization of TRPV1 
does not depend on its glycosylation state, and both 
V1/2  of  activation.  Third,  TRPV1  activation  results  in 
minimal responsiveness of KCNQ2/3 to the KCNQ 
channel opener retigabine in both electrophysiological 
and Tl
+ influx assays. This insensitivity to channel mod-
ulation could be caused by the dual effects on KCNQ2/3 
channels as a result of TRPV1 coexpression and activa-
tion. Although the major effect of retigabine on KCNQ 
channels is a hyperpolarizing shift of the half-activation 
voltage, this stimulatory effect is significantly attenuated 
by the depolarized shift in activation threshold caused 
by  coexpression,  and  the  reduced  conductance  by 
KCNQ2/3 caused by activation of TRPV1.
The rapid effect on KCNQ2/3 activity in response to 
TRPV1 activation suggests that this process does not in-
volve a sudden change in expression level or redistribu-
tion of KCNQ2/3 channels on the plasma membrane. 
The lack of inhibitory effect of TRPV1 on KCNQ2/3 in 
the absence of extracellular Ca
2+ observed in our assays 
suggests that Ca
2+ influx through the activated TRPV1 
channel may cause cellular events that lead to inhibition 
of KCNQ2/3 channel activity. Inhibition of KCNQ2/3 
channels  by  Ca
2+-mediated  mechanisms  has  been  re-
ported for heterologously expressed channels and in 
rat sympathetic neurons (Selyanko and Brown, 1996; 
Gamper and Shapiro, 2003). For example, bradykinin 
inhibits the KCNQ current via Ca
2+ release from IP3-
sensitive Ca
2+ stores in sympathetic neurons (Cruzblanca 
et al., 1998). Similarly, Ca
2+ influx through activated 
TRPV1 channels could mobilize sufficient Ca
2+ into 
cells to inhibit KCNQ2/3.
Ca
2+  influx  through  activated  TRPV1  may  inhibit 
KCNQ2/3 channel activity by several possible mechanisms.   
The loss of inhibitory effect on KCNQ2/3 in the pres-
ence of excess PIP2 or the calcineurin inhibitor suggests 
that depletion of PIP2 from the cell membrane and 
activation of calcineurin contribute to functional inhibi-
tion of KCNQ2/3 by TRPV1 activation. The C-terminal 
Figure  7.  TRPV1  colocalizes  and  interacts  with 
KCNQ2 in DRGs. (A) Rat DRG protein extracts were 
prepared  and  subjected  to  immunoprecipitation 
(IP) by anti-KCNQ2 antibody. Western blot analysis of 
coimmunoprecipitation of TRPV1 is shown. (B) Pro-
tein extracts from HEK293 cells expressing either 
KCNQ2 or TRPV1 were prepared and subjected to 
Western blot analysis. KCNQ2- and TRPV1-specific 
bands detected with corresponding antibodies are 
shown.  Western  blots  shown  are  representative  of 
experiments repeated twice. (C) Representative im-
munofluorescence  images  (experiments  repeated 
at least three times) of DRG neurons from rat DRG 
sections stained with anti-TRPV1 antibody (1, red) 
or anti-KCNQ2 antibody (2, green) are shown. The 
combined image revealed that KCNQ2 and TRPV1 
colocalize in small- and medium-sized DRG neurons 
(3, yellow).  Zhang et al. 351
physically associate with each other under physiological 
conditions. TRPV1 in nociceptors plays a key role in 
pain after inflammation or tissue injury. The findings 
from  our  study  suggest  that  the  inhibitory  effects  of 
TRPV1 on KCNQ2/3 channels may reduce the activa-
tion thresholds of the nociceptor to other stimuli. In 
this regard, it is interesting to note that diverse stimuli 
not only directly activate TRPV1 but also sensitize and 
reduce the activation thresholds of the channel to other 
stimuli (Di Marzo et al., 2002). Besides, intradermal in-
jection of capsaicin or sensitization of TRPV1 signaling 
by inflammatory mediators induces heat and mechani-
cal hyperalgesia or allodynia (Simone, 1992). Among sev-
eral possible mechanisms, TRPV1-mediated KCNQ2/3 
inhibition may lower the threshold for nociceptor activa-
tion, which could indirectly help TRPV1 to integrate 
diverse  noxious  stimuli  and  establish  hyperalgesia 
and allodynia. Besides DRG neurons, the expression of 
KCNQ and TRPV1 channels has been detected in the 
central nervous system where TRPV1 can be activated 
by endogenous ligands such as anandamide (Jentsch, 
2000; Szallasi and Di Marzo, 2000; Di Marzo et al., 
2008). It remains to be explored whether there are sim-
ilar physical and functional interactions between these 
two channels at those sites.
In summary, we report on the novel finding of sup-
pression of KCNQ2/3 channel activity by the coexpres-
sion and activation of TRPV1. The functional interaction 
between these two ion channels could have important 
pathophysiological consequences in that it could impact 
the severity of chronic pain.
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highly  glycosylated  and  less  glycosylated  forms  of 
TRPV1 have been detected in the plasma membrane 
(Vos et al., 2006). However, we cannot ascertain through 
coimmunoprecipitation  assays  whether  their  interac-
tion is direct or mediated by other proteins. In addi-
tion, because the site responsible for interaction appears 
to map to the region containing the six transmembrane 
domains of TRPV1 and KCNQ2/3, an intact membrane 
structure may also be necessary. Two lines of observa-
tion suggest that TRPV1 and KCNQ can still form inde-
pendent channels, although they associate with each 
other. First, coimmunoprecipitation revealed an appar-
ently  more  robust  interaction  between  KCNQ2  and 
KCNQ3 than between TRPV1 and KCNQ subunits. Sec-
ond,  electrophysiological  and  pharmacological  assays 
support the existence of independent TRPV1 and KCNQ 
channels with expected channel properties. We speculate 
that TRPV1 and KCNQ2/3 may form or be part of an ion 
channel macrocomplex by association with each other.
Data from our study of a functionally deficient TRPV1 
mutant  indicates  that  physical  association  of  TRPV1 
with KCNQ2/3 accounts for the depolarized shift of the 
voltage dependence of KCNQ2/3 activation. The asso-
ciation with TRPV1 may physically cause a conforma-
tional  change  of  the  KCNQ2/3  channel  and  hence 
affect the gating of the channel. Moreover, a physical 
interaction may also facilitate a fast and localized rise in 
Ca
2+ concentration when TRPV1 is activated, which may 
be required for inhibition of KCNQ2/3 activity. Such an 
effect contributes to the differential outcome of stimu-
lation of bradykinin versus muscarinic receptors (Delmas 
et al., 2002). Although activation of both receptors rap-
idly produces InsP3 as a second messenger, only activa-
tion of the bradykinin receptor subsequently results in 
activation of the IP3 receptor because of their close cou-
pling. Similarly, the association of TRPV1 with KCNQ2/3 
may provide the basis and define the specificity of inhi-
bition  of  KCNQ  activity  by  TRPV1.  Indeed,  a  recent 
study revealed that lipid rafts are needed to colocalize 
both muscarinic receptors and KCNQ2/3 channels to 
enable receptor-mediated suppression of channel activ-
ity (Oldfield et al., 2009). One way to assess the possible 
role of colocalization is to study mutant KCNQ2/3 or 
TRPV1 channels that disrupt their physical association.
M currents have been identified in sensory neurons, 
and the expression of KCNQ2-5 subunits has been re-
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2003). A large percentage of small DRG neurons, which 
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reported  to  be  sensitive  to  capsaicin,  the  agonist  for 
TRPV1 whose expression has been detected in small- and 
medium-sized  DRG  neurons  (Caterina  et  al.,  1997; 
Vos et al., 2006). Our observation of colocalization of 
TRPV1 and KCNQ channels in small- and medium-sized 
DRG neurons is consistent with these earlier reports. 
More interestingly, we observed that these two channels 352 TRPV1 activation suppresses the KCNQ2/3 channel
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